Research Article

Sex-Related Differences in Outcomes for Oropharyngeal Squamous Cell Carcinoma by HPV Status

Table 1

Baseline cohort characteristics by sex.

HPV positiveHPV negative
CharacteristicMen N = 8,860Women N = 1,350 valueMen N = 3,020Women N = 953 value

Age category, median (IQR)60–64 (50–69)60–64 (55–69)<0.00160–64 (55–69)60–64 (55–74)<0.001

Race/ethnicity, N (%)
 Caucasian7,613 (85.9)1,103 (81.7)0.0012,270 (75.2)731 (76.7)0.06
 African American454 (5.1)98 (7.3)394 (13.1)118 (12.4)
 Hispanic509 (5.7)93 (6.9)223 (7.4)52 (5.5)
 Asian or Pacific Islander200 (2.3)43 (3.2)104 (3.4)46 (4.8)
 Other/unknown84 (1.0)13 (1.0)29 (1.0)6 (0.6)

Year of diagnosis, N (%)
 2010445 (5.0)64 (4.7)0.90227 (7.5)58 (6.1)0.10
 2011676 (7.6)114 (8.4)358 (11.9)125 (13.1)
 2012986 (11.1)158 (11.7)414 (13.7)126 (13.2)
 20131,312 (14.8)205 (15.2)479 (15.9)140 (14.7)
 20141,575 (17.8)238 (17.6)519 (17.2)153 (16.1)
 20151,777 (20.1)260 (19.3)464 (15.4)182 (19.1)
 20162,089 (23.6)311 (23.0)559 (18.5)169 (17.7)

Stage at diagnosis, N (%)
 I5,098 (57.5)878 (65.0)<0.001214 (7.1)121 (12.7)<0.001
 II2,097 (23.7)255 (18.9)250 (8.3)101 (10.6)
 III1,451 (16.4)181 (13.4)563 (18.6)170 (17.8)
 IV214 (2.4)36 (2.7)
 IVA1,517 (50.2)427 (44.8)
 IVB296 (9.8)77 (8.1)
 IVC180 (6.0)57 (6.0)

Clinical T∗, N (%)
 061 (0.7)6 (0.4)<0.0015 (0.2)4 (0.4)0.004
 12,504 (28.3)470 (34.8)649 (21.5)251 (26.3)
 23,560 (40.2)542 (40.2)1,004 (33.3)284 (29.8)
 31,525 (17.2)165 (12.2)662 (21.9)181 (19.0)
 41,210 (13.7)167 (12.4)
 4a467 (15.5)157 (16.5)
 4b174 (5.8)66 (6.9)
 Missing59 (2.0)10 (1.0)

Clinical N, N (%)
 01,178 (13.3)247 (18.3)<0.001746 (24.7)325 (34.1)<0.001
 15,751 (64.9)871 (64.5)533 (17.7)166 (17.4)
 21,534 (17.3)198 (14.7)31 (1.0)10 (1.1)
 2a217 (7.2)57 (6.0)
 2b797 (26.4)216 (22.7)
 2c468 (15.5)140 (14.7)
 3397 (4.5)34 (2.5)177 (5.9)29 (3.0)
 Missing51 (1.7)10 (1.0)
Median county Household income, $63,88063,2500.1061,02061,0200.45
% County education, median
 <9th grade5.185.290.975.264.880.13
 < High school12.1012.320.5212.5012.450.05
 ≥ Bachelors32.5931.930.3531.2331.230.33

Insurance, N (%)
 Uninsured239 (2.7)26 (1.9)<0.001132 (4.4)36 (3.8)0.41
 Any Medicaid783 (8.8)158 (11.7)521 (17.3)182 (19.1)
 Insured6,702 (75.6)960 (71.1)1,871 (62.0)567 (59.5)
 Insured (no specifics)1,036 (11.7)184 (13.6)441 (14.6)153 (16.1)
 Unknown100 (1.1)22 (1.6)55 (1.8)15 (1.6)

Marital status, N (%)
 Single2,835 (32.0)612 (45.3)<0.0011,309 (43.3)508 (53.3)<0.001
 Married5,620 (63.4)681 (50.4)1,576 (52.2)382 (40.1)
 Unknown405 (4.6)57 (4.2)135 (4.5)63 (6.6)

HPV, human papillomavirus; IQR, interquartile range, HPV positive: 16.0% clinical, 7.5% pathologic; HPV negative: 13.7% clinical, 4.5% pathologic; the rest based on best available information as determined by SEER. HPV positive: 16.8% clinical, 6.7% pathologic; HPV negative: 14.4% clinical, 3.8% pathologic; the rest based on best available information as determined by SEER.